FDA Approves Moderna Covid Vaccine sBLA
FDA has approved a Moderna sBLA for Spikevax, the company’s Covid-19 vaccine, in children aged six months through 11 years who are at increased risk for Covid-19 disease. A company statement says the FDA full approval replaces the previous emergency use authorization.